Philippe Amouyal Lexicon Pharmaceuticals, Inc. (LXRX) insider trading activity

Philippe Amouyal is Director of LEXICON PHARMACEUTICALS, INC.. Currently has a direct ownership of 285,174 shares of LXRX, which is worth approximately $211,028. The most recent transaction as insider was on May 13, 2025, when has been sold 36,810 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 285K

14.82% 3M change

14.82% 12M change

Total Value Held $211,028

Philippe Amouyal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 13 2025	BUY Exercise of conversion of derivative security	-	36,810 Added 11.43%	285,174 Common Stock
Apr 28 2024	BUY Exercise of conversion of derivative security	-	8,032 Added 3.13%	248,364 Common Stock
May 21 2023	BUY Exercise of conversion of derivative security	-	9,302 Added 18.74%	40,332 Common Stock
Apr 30 2022	BUY Exercise of conversion of derivative security	-	4,024 Added 11.48%	31,030 Common Stock
Apr 24 2021	BUY Exercise of conversion of derivative security	-	10,638 Added 28.26%	27,006 Common Stock

Also insider at

CAVA

CAVA GROUP, INC.

Director